Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Cazzaniga, Marina, Verusio, Claudio, Ciccarese, Mariangela, Fumagalli, Alberto, Sartori, Donata, Valerio, Maria Rosaria, Airoldi, Mario, Moretti, Gabriella, Ficorella, Corrado, Arcangeli, Valentina, Diodati, Lucrezia, Zambelli, Alberto, Febbraro, Antonio, Generali, Daniele, Pistelli, Mirco, Garrone, Ornella, Musolino, Antonino, Vici, Patrizia, Maur, Michela, Mentuccia, Lucia, La Verde, Nicla, Bianchi, Giulia, Artale, Salvatore, Blasi, Livio, Piezzo, Matilde, Atzori, Francesco, Turletti, Anna, Benedetto, Chiara, Cursano, Maria Concetta, Fabi, Alessandra, Gebbia, Vittorio, Schirone, Alessio, Palumbo, Raffaella, Ferzi, Antonella, Frassoldati, Antonio, Scavelli, Claudio, Clivio, Luca, Torri on behalf of The EVA Study Group, Valter
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2018
Teme:
Correction
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6195381/
https://ncbi.nlm.nih.gov/pubmed/30349655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26213
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki